Exyte

At Exyte, here’s how we blow off some steam. 💪 Recently, our colleagues in Singapore turned-on their out-of-office notifications for Exyte Wellness Day, a refreshing afternoon of health, well-being, and self-care. The event featured several games and activities designed to recharge our colleagues and promote physical and mental well-being. Our people are some of the hardest working individuals who are building a better and more advanced future. At Exyte, we leave no stone unturned in supporting their happiness and well-being. It's initiatives like Exyte Wellness Day that allow our colleagues to pause, find their balance, and prioritize their health. Here are a few glimpses of the event. 👇

That’s a wrap at DCD Virginia. Here’s a recap. Exyte was proud to sponsor the DCD Leadership Summit. From identifying new collaboration opportunities to having engaging conversations with industry peers, our data center team demonstrated what the future of data centers could look like, and how Exyte is setting the pace. During the event, we hosted a session that brought together industry leaders from renowned companies. Damian Farr, President of Exyte’s Data Center Business Unit, shared how Exyte leverages Offsite Manufacturing (OSM) to boost efficiency, reduce delays, and enhance safety and predictability. The turning point of the session was Damian’s presentation on Kit of Parts, Exyte’s building block approach to accelerate delivery while tailoring projects to our clients' needs. Our Kit of Parts philosophy provides a library of proven, prefabricated elements that can be adapted and combined to suit each data center. This enables us to apply OSM quickly and effectively, capturing value at every stage. “We are seeing up to 30 percent shaved off schedules,” said Damian, emphasizing that together with our subsidiary Exentec, we can reduce lead times by executing work directly and eliminating the delays often associated with subcontractors. Want to learn more about our data center solutions? Visit here: https://lnkd.in/ebq5kp2m Here are a few snapshots of the DCD Leadership Summit. 👇

We are happy to announce that Exyte has completed the integration of Pharmaplan, marking the full transition of the Pharmaplan brand to Exyte and unifying biopharma engineering capabilities under one organization. This milestone follows Exyte’s 2024 acquisition of Pharmaplan to strengthen partnerships with Europe’s dynamic biotechnology and pharmaceutical sectors. Pharmaplan’s pan-European footprint and specialist teams are now part of Exyte’s Biopharma & Life Sciences organization. Market and client feedback has been strongly positive. This is reflected in major wins, robust business acquisition, and a very strong order-intake development in 2025. Exyte’s Biopharma & Life Sciences global business unit is on track to reach a record order-intake level this year. “Bringing Pharmaplan fully into Exyte combines global delivery scale with five decades of life-sciences process and GMP expertise,” says Dr. Wolfgang Büchele, CEO of Exyte. “Our clients benefit from seamless EPC solutions, from concept design to compliant handover. We deliver with speed, precision, and reliability. Facilities are where pharmaceutical innovation becomes real.” Learn more: https://shorturl.at/TOHzI

Exyte had a fantastic time exhibiting at ISPE Ireland 2025! Our booth was buzzing with excitement, energy, and innovation in biopharma and life sciences. We showcased cutting-edge technologies and solutions, including Rexyte, our robodog from Boston Dynamics, as well as ExyCell® and ExyVision. These solutions offer exceptional capabilities in modularity, predictability, and digital visualization for facility design. Throughout the event, we enjoyed engaging in conversations with clients and industry peers, strengthening partnerships and exploring new opportunities for collaboration. A highlight of the event was the presentation by Aisling Crowley, Senior Vice President of Business Acquisition, on innovation at Exyte. Rexyte even joined her on stage, generating strong interest and engagement from attendees. Thank you to everyone who visited our booth and contributed to a successful event. Here are a few glimpses. 👇

Black Semiconductor partners with Exyte to build a production line for next-generation chip technology. In Germany, we are collaborating with Black Semiconductor on FabONE, the world’s first fabrication facility designed to manufacture photonics using graphene on 300mm wafers. Exyte will plan, design, and build the cleanroom for this groundbreaking production line, enabling a technology, that can revolutionize high-speed, low-power semiconductor solutions. For decades, Exyte has helped build and expand semiconductor ecosystems around the world, from first pilot lines to large-scale manufacturing sites. FabONE represents an important piece in the renaissance of Europe’s semiconductor sector and the strengthening of the ecosystem across the entire value chain. As a leading EPC specialist for advanced technology facilities, Exyte is driving growth in both scale and innovation, across Europe and particularly in Germany.

Exyte welcomes Werner Greyling as its second Chief Operating Officer and member of the Executive Board. Effective December 1st, 2025, and based in the United States, Greyling will oversee operations in the USA region and, together with Board member and Chief Operating Officer Jürgen Raschendorfer, assume joint responsibility for global operations leadership, strengthening project execution in all regions. Greyling brings over 25 years of experience in engineering, project delivery, and operational leadership, with extensive expertise in large-scale, high-tech facility construction. He previously worked for Exyte’s predecessor company, M+W Group, and later held senior leadership positions in several renowned companies. “Joining Exyte at this pivotal juncture is a great opportunity. My priority is to drive operational rigor, sharpen our delivery performance in the U.S. and globally, and ensure that our execution lives up to the promise we make to clients and stakeholders,” says Greyling. As Werner Greyling embarks on this new journey, we have every confidence that his leadership and experience will have a significant impact on Exyte’s global operations. With this in mind, we wish him all the best in this new endeavor.

Battery technology is at the heart of modern innovation. From powering everyday devices like smartphones and laptops to driving the global shift toward renewable energy, batteries have become essential to daily life. As demand continues to charge up, Exyte is committed to advancing global battery markets with innovative facility solutions. Nicole Neub, Director of Battery Technology at Exyte’s subsidiary Exentec, is driving this momentum forward. With experts like Nicole, we create a better future. Discover more about Nicole Neub and her insights into Mini Environments, a mini dry room solution that is sustainable, low cost, and enables high quality battery production: https://bit.ly/3JR31Tb #WeCreateABetterFuture

Kate Shaughnessy, MBA is a Senior Document Control Specialist at Exyte, having joined the company in 2024. In her role, she sets up and maintains project DMCS platforms, ensuring files are well-structured, accessible, and reliable. She also supports colleagues in navigating these systems so that every project runs efficiently, with data integrity at its core. Coming from outside the industry, Kate’s biggest learning curve has been understanding how all the processes come together to create a large-scale facility. She embraces this challenge with curiosity and determination, constantly working to connect the dots and expand her technical knowledge. To help drive Exyte to the Next Level, Kate brings a fresh perspective. She isn’t afraid to ask “why," questioning established methods and exploring smarter, more efficient ways of working. A pleasant surprise about Exyte was exceptional support from her team and manager, who have made the learning process not only easier but inspiring.

What’s the most effective path to a control strategy in biopharma and life sciences? A control strategy is a key deliverable during the pharmaceutical development stages of the CMC product lifecycle. It ensures that a product of the required quality is produced consistently. In this latest BioPhorum feature, Antonello Finucci, Director of Process Digitalization, together with fellow industry experts, explores why organizations remain stuck in "minimal control strategies," contributing insights from his experience. He outlines several effective steps for successfully implementing a control strategy, including identifying the right roles and responsibilities, leveraging structured data and smarter tools, and more. Read the complete article here: https://bit.ly/4qCSLyq

Engineering solutions to create a greener tomorrow. Nikolay Goleshov is a Senior Mechanical Engineer at Exyte. With years of experience, he has played a key role in a large-scale semiconductor fab project in Singapore. The fab addresses one of the semiconductor industry’s biggest environmental challenges: greenhouse gas emissions. On this project, Nikolay helped design a powerful alternative to traditional individual abatement systems, which are typically attached to each manufacturing tool. His solution was a centralized abatement system that can tackle perfluorocarbons, a potent greenhouse gas with high global warming potential. Discover more about this unique project and Nikolay’s centralized solution that significantly reduces harmful emissions: https://bit.ly/3WxiR8k #WeCreateABetterFuture